Christopher J. Moreau
Chief Executive Officer
Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and a deep expertise in the capital markets. Mr. Moreau was previously President & CEO and Director of a publicly traded company, where he raised in excess of $13 million to fund research & development for screening tests for prostate cancer, skin cholesterol and type 2 diabetes. He also has over 25 years of senior management experience in private & publicly traded company environments.
Mark Williams PhD MBA
Chief Science Officer
Mark has 15 years of experience in drug and medical device development having repurposed 3 drugs from preclinical studies directly to positive phase II data. He was also the inventor of a recombinant protein and helped oversee its development from manufacturing into phase II trials for his previously NASDAQ traded company.
Michael Sadhra CA
Chief Financial Officer & Director
Mr. Sahdra was a Former Senior Tax Manager at KPMG and is currently aTax Partner Sadhra Chow LLP. He has Served as CFO and as Director of Numerous Public Companies.